PBSV · Pharma-Bio Serv, Inc.
4 customers — 19.8% of revenue (three months ended April 30, 2026)
“During the three months ended April 30, 2026, revenues from these customers were 19.8%, 16.5%, 12.4% and 5.9%, or a total of 54.6%”
4 customers — 19.8% of revenue (three months ended April 30, 2026)
“During the three months ended April 30, 2026, aggregate revenues from these global groups of affiliated companies were 19.8%, 16.5%, 14.2% and 5.9%, or a total of 56.4%”
4 customers — 18.5% of revenue (six months ended April 30, 2026)
“During the six months ended April 30, 2026, revenues from these customers were 18.5%, 16.1%, 12.9% and 7.4%, or a total of 54.9%”
4 customers — 18.5% of revenue (six months ended April 30, 2026)
“During the six months ended April 30, 2026, aggregate revenues from these global group of affiliated companies were 18.5%, 16.1%, 14.6% and 7.4%”
4 customers — 16.5% of revenue (three months ended April 30, 2026)
“During the three months ended April 30, 2026, aggregate revenues from these global groups of affiliated companies were 19.8%, 16.5%, 14.2% and 5.9%, or a total of 56.4%”
4 customers — 16.5% of revenue (three months ended April 30, 2026)
“During the three months ended April 30, 2026, revenues from these customers were 19.8%, 16.5%, 12.4% and 5.9%, or a total of 54.6%”
4 customers — 16.1% of revenue (six months ended April 30, 2026)
“During the six months ended April 30, 2026, aggregate revenues from these global group of affiliated companies were 18.5%, 16.1%, 14.6% and 7.4%”
4 customers — 16.1% of revenue (six months ended April 30, 2026)
“During the six months ended April 30, 2026, revenues from these customers were 18.5%, 16.1%, 12.9% and 7.4%, or a total of 54.9%”
4 customers — 14.6% of revenue (six months ended April 30, 2026)
“During the six months ended April 30, 2026, aggregate revenues from these global group of affiliated companies were 18.5%, 16.1%, 14.6% and 7.4%”
4 customers — 14.2% of revenue (three months ended April 30, 2026)
“During the three months ended April 30, 2026, aggregate revenues from these global groups of affiliated companies were 19.8%, 16.5%, 14.2% and 5.9%, or a total of 56.4%”
4 customers — 12.9% of revenue (six months ended April 30, 2026)
“During the six months ended April 30, 2026, revenues from these customers were 18.5%, 16.1%, 12.9% and 7.4%, or a total of 54.9%”
4 customers — 12.4% of revenue (three months ended April 30, 2026)
“During the three months ended April 30, 2026, revenues from these customers were 19.8%, 16.5%, 12.4% and 5.9%, or a total of 54.6%”
4 customers — 7.4% of revenue (six months ended April 30, 2026)
“During the six months ended April 30, 2026, aggregate revenues from these global group of affiliated companies were 18.5%, 16.1%, 14.6% and 7.4%”
4 customers — 7.4% of revenue (six months ended April 30, 2026)
“During the six months ended April 30, 2026, revenues from these customers were 18.5%, 16.1%, 12.9% and 7.4%, or a total of 54.9%”
4 customers — 5.9% of revenue (three months ended April 30, 2026)
“During the three months ended April 30, 2026, aggregate revenues from these global groups of affiliated companies were 19.8%, 16.5%, 14.2% and 5.9%, or a total of 56.4%”
4 customers — 5.9% of revenue (three months ended April 30, 2026)
“During the three months ended April 30, 2026, revenues from these customers were 19.8%, 16.5%, 12.4% and 5.9%, or a total of 54.6%”
4 customers — 47.1% of receivables (April 30, 2026)
“On April 30, 2026, amounts due from these customers represented 47.1% of the Company’s total accounts receivable balance.”
Private capital raises reported to the SEC on Form D under Regulation D, showing the offering size, amount sold, minimum investment and number of investors. Public operating companies rarely raise capital this way, so this page is often empty.
No Exempt Offerings
No Form D exempt-offering notices are available for this stock yet.